BMJ

Enteric-coated mycophenolate sodium versus azathioprine in patients with active systemic lupus erythematosus: a randomised clinical trial

Correspondence to Dr Josefina Cortés-Hernández, Systemic Autoimmune Diseases Research Unit, Internal Medicine Department, Vall d’Hebrón University Hospital Research Institute, Passeig Vall d’Hebrón ...
BMJ

OP0283 MYCOPHENOLATE MOFETIL VS CYCLOPHOSPHAMIDE FOR TREATMENT OF LUPUS NEPHRITIS: A SINGLE-CENTER COHORT REAL-WORLD ANALYSIS

Background Mycophenolate mofetil (MMF) or low-dose intravenous cyclophosphamide (CYC) are recommended as initial (induction) treatment in many recommendations for the management of lupus nephritis (LN ...
BMJ

Efficacy and safety of ustekinumab in psoriatic arthritis patients with peripheral arthritis and physician-reported spondylitis: post-hoc analyses from two phase III ...

Objective To evaluate ustekinumab efficacy and safety in psoriatic arthritis (PsA) patients with peripheral arthritis and physician-reported spondylitis (termed the ‘spondylitis subset’). Methods ...
BMJ

Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke

2 Department of Medicine, Rheumatology Unit, Karolinska Institutet/Karolinska Hospital, Stockholm, Sweden 3 Unit of Clinical Immunology, Uppsala University/Akademiska Sjukhuset, Uppsala, Sweden 4 ...
BMJ

Knee pain and osteoarthritis in older adults: a review of community burden and current use of primary health care

Dr G Peat, Primary Care Sciences Research Centre, School of Postgraduate Medicine, Keele University, The Medical Institute, Hartshill Road, Stoke-on-Trent ST7 4NY, UKg.m.peat{at}hfac.keele.ac.uk ...
BMJ

Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide

Introduction: Potential hepatotoxicity associated with disease-modifying antirheumatic drugs (DMARDs) requires laboratory monitoring. In patients with rheumatoid arthritis (RA) or psoriatic arthritis ...
BMJ

NT-proBNP predicts mortality in patients with rheumatoid arthritis: results from 10-year follow-up of the EURIDISS study

Objectives Patients with rheumatoid arthritis (RA) have a higher mortality than the general population, and this increased mortality is related to demographic and disease variables. N-terminal ...
BMJ

Prediction of progression of interstitial lung disease in patients with systemic sclerosis: the SPAR model

Objectives To identify the predictive clinical characteristics and establish a prediction model for the progression of mild interstitial lung disease (ILD) in patients with systemic sclerosis (SSc).
BMJ

Development and initial validation of a screening questionnaire for psoriatic arthritis: the Toronto Psoriatic Arthritis Screen (ToPAS)

1 Toronto Western Research Institute, Psoriatic Arthritis Program, Centre for Prognosis Studies in The Rheumatic Diseases, University Health Network, Toronto Western Hospital, Toronto, Ontario, Canada ...
BMJ

Rheumatoid arthritis in Spain: occurrence of extra-articular manifestations and estimates of disease severity

5 Rheumatology Department, H Germans Trias i Pujol, Badalona, Spain 6 Rheumatology Department, H Clinic i Provincial, Barcelona, Spain Correspondence to: Dr L Carmona, Sociedad Española de ...
BMJ

QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries

Objective: To conduct a cross-sectional review of non-selected consecutive outpatients with rheumatoid arthritis (RA) as part of standard clinical care in 15 countries for an overview of the ...
BMJ

Oral sildenafil for the treatment of Raynaud’s phenomenon and digital ulcers secondary to systemic sclerosis

Medical University of South Carolina, Division of Rheumatology, Charleston, South Carolina, USA Correspondence to: Dr J Gore Medical University of South Carolina, Division of Rheumatology, 96 Jonathon ...